Influence of water extract of Mexican sunflower (Tithonia diversifolia) on growth of cowpea (Vigna unguiculata)

Laboratory analysis of the water extract of Tithonia diversifolia shoot and root on infra-red spectrometer to determine the phytotoxic potential and greenhouse experiments to evaluate its phytotoxic effect and growth promoting attribute on cowpea (Vigna unguiculata L.) were carried out. T. diversifolia contained some compounds having functional groups such as alcohols, olefins, six-membered ring lactams, ester, aromatic compound which can also be found in sesquiterpene lactones, an allelochemical implicated in phytotoxicity. The extract promoted seedling and plant growth. Bacillus and Streptococcus spp. earlier isolated from the root rhizosphere of T. diversifolia caused some changes in the spectra of the component compounds in the extract. The plant extract promoted growth of cowpea.African Journal of Biotechnology Vol. 4 (4), pp. 355-360, 200

Sea floor bedforms and their influence on slope accommodation (2019)

We sincerely thank Petroleum Geo-Services (PGS) Investigação Petrolífera Limitada, and specifically David Hajovsky and Scott Opdyke, that kindly provided the dataset and allowed us to show these results. We would also like to thank Schlumberger for providing academic licenses of their software (Petrel). We are grateful to Associate Editor Kei Ogata for his support, and we sincerely thank reviewers Daniele Casalbore and Kamaldeen Omosanya for their comments and suggestions that significantly improved the quality of the manuscript.Peer reviewedPostprin

Antiproliferative, antioxidant and antiplasmodial activities of the root bark of Adenodolichos paniculatus (Hua) Hutch (Fabaceae)

Adenodolichos paniculatus Hua & Hutch (Fabaceae) is a plant whose roots are traditionally employed for the treatment of non-communicable diseases such as diabetes and cancer. The powdered root bark of Adenodolichos paniculatus were extracted with dichloromethane followed by 70% methanol to afford dichloromethane (DCM) and hydromethanolic (HME) extracts respectively. Thereafter, fresh powdered root was extracted with water via decoction method and lyophilized to afford aqueous extract (AQE). The extracts were then subjected to standard phytochemical studies, antiproliferative (A2780 ovarian cancer cell assay), antiplasmodial (Dd2 strain of Plasmodium falciparum), antioxidant (DPPH, FRAP and ABTS methods) and brine shrimp lethality assay studies. The DCM extract was found to possess high levels of total phenolics and flavonoids with notable potential antiproliferative (IC50 = 0.14 μg/ml), antiplasmodial (IC50 = 7.50 μg/ml) and cytotoxic (brine shrimp, IC50 = 0.547 μg/ml) activities. However, HME had significant antioxidant (DPPH, IC50 = 17.54 ± 0.03 μg/ml; ABTS, IC50 = 8.08 ± 0.05 μg/ml). Both HME and AQE were found to be inactive against the drug-resistant Dd2 strain of Plasmodium falciparum with an IC50 value ˃100μg/mL. The study revealed the potential of Adenodolichos paniculatus as a promising antiproliferative agent and also corroborated the ethnomedical uses of the plant

Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice

\ua9 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. Basic Science is crucial for the advancement of clinical care for Movement Disorders. Here, we provide brief updates on how basic science is important for understanding disease mechanisms, disease prevention, disease diagnosis, development of novel therapies and to establish the basis for personalized medicine. We conclude the viewpoint by a call to action to further improve interactions between clinician and basic scientists. \ua9 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri

Background: Hyperprolactinaemia among patients on antipsychotic medications is generally overlooked due to lack of outwardly visible symptoms, patient resistance to reporting because the symptoms are perceived as shameful, or to clinician’s insufficient knowledge. Aim: The study aimed to evaluate the patterns and correlates of hyperprolactinemia among patients with schizophrenia on antipsychotic medications. Setting: The study was conducted in a psychiatric facility in Maiduguri, Northeastern Nigeria. Methods: A total of 209 patients with schizophrenia were evaluated through a cross-sectional design and assayed for serum prolactin with ELISA Kits. Frequencies and percentages were tabulated for categorical variables. Variables with significant associations with hyperprolactinaemia on chi-square (p  0.05) were subjected to logistic regression analysis. Results: The prevalence of hyperprolactinaemia was 45.9% in all patients on antipsychotic medication. The prevalence because of the use of typical and atypical antipsychotics was 51.5% and 25.0%, respectively. Hyperprolactinaemia was significantly associated with typical antipsychotics (β = 0314, p = 0.002), high overall drug dosage (β = 2.340, p = 0.003), high-dose typical antipsychotics (β = 3.228, p = 0.000), twice daily dosing frequency (β = 2.751, p = 0.001) and polypharmacy (β = 1.828, p = 0.0024). Conclusion: The findings support that patients on typical, high-dose antipsychotic medications and polypharmacy have a high prevalence of hyperprolactinaemia. As hyperprolactinaemia is often undetectable, screening and patient psycho-education on the significance of the signs and symptoms of hyperprolactinaemia is required for necessary clinical intervention. Contribution: The study provides evidence for the rational use of antipsychotic medications in sub-Saharan Africa

Surveillance of bacterial pathogens of diarrhoea in two selected sub metros within the Accra metropolis

Background: In recent years, many localities within the Greater Accra Region (GAR) have witnessed several episodes of cholera outbreaks, with some deaths.Compared to previous epidemics, which usually followed heavy rains, recent outbreaks show no seasonality.Objectives: To investigate infective bacterial diseases in selected sub metros within the GAR.Methods: We used existing disease surveillance systems in Ghana, and investigated all reported cases of diarrhoea that met our case-definition. A three-daytraining workshop was done prior to the start of study, to sensitize prescribers at the Korle-Bu Polyclinic and Maamobi General hospital. A case-based investigationform was completed per patient, and two rectal swabs were taken for culture at the National Public Health and Reference Laboratory. Serotyping and antibiogramprofiles of identified bacteria were determined. Potential risk factors were also assessed using a questionnaire.Results: Between January and June 2012, a total of 361 diarrhoeal cases with 5 deaths were recorded. Out of a total of 218 rectal swabs cultured, 71 (32.6%) Vibrio cholerae O1 Ogawa serotypes, and 1 (0.5%) Salmonella (O group B) were laboratory confirmed. No Shigella was isolated. The Vibrio cholerae isolates were susceptible to ciprofloxacin and tetracycline. Greater than 80% of patients reported having drank sachet water 24 h prior to diarrhoea onset, and many (144/361) young adults (20-29 years) reported with diarrhoea.Conclusion: Enhanced surveillance of diarrhoeal diseases (enteric pathogens) within cholera endemic regions, will serve as an early warning signal, and reduce fatalities associated with infective diarrhoea.Keywords: Diarrhoeal disease surveillance, enteric pathogens, Vibrio cholerae, Salmonell

Clinical use of HIV integrase inhibitors : a systematic review and meta-analysis

Background: Optimal regimen choice of antiretroviral therapy is essential to achieve long-term clinical success. Integrase inhibitors have swiftly been adopted as part of current antiretroviral regimens. The purpose of this study was to review the evidence for integrase inhibitor use in clinical settings. Methods: MEDLINE and Web-of-Science were screened from April 2006 until November 2012, as were hand-searched scientific meeting proceedings. Multiple reviewers independently screened 1323 citations in duplicate to identify randomized controlled trials, nonrandomized controlled trials and cohort studies on integrase inhibitor use in clinical practice. Independent, duplicate data extraction and quality assessment were conducted. Results: 48 unique studies were included on the use of integrase inhibitors in antiretroviral therapy-naive patients and treatment-experienced patients with either virological failure or switching to integrase inhibitors while virologically suppressed. On the selected studies with comparable outcome measures and indication (n = 16), a meta-analysis was performed based on modified intention-to-treat (mITT), on-treatment (OT) and as-treated (AT) virological outcome data. In therapy-naive patients, favorable odds ratios (OR) for integrase inhibitor-based regimens were observed, (mITT OR 0.71, 95% CI 0.59-0.86). However, integrase inhibitors combined with protease inhibitors only did not result in a significant better virological outcome. Evidence further supported integrase inhibitor use following virological failure (mITT OR 0.27; 95% CI 0.11-0.66), but switching to integrase inhibitors from a high genetic barrier drug during successful treatment was not supported (mITT OR 1.43; 95% CI 0.89-2.31). Integrase inhibitor-based regimens result in similar immunological responses compared to other regimens. A low genetic barrier to drug-resistance development was observed for raltegravir and elvitegravir, but not for dolutegravir. Conclusion: In first-line therapy, integrase inhibitors are superior to other regimens. Integrase inhibitor use after virological failure is supported as well by the meta-analysis. Careful use is however warranted when replacing a high genetic barrier drug in treatment-experienced patients switching successful treatment

Effects of Externally Rated Job Demand and Control on Depression Diagnosis Claims in an Industrial Cohort

This study examined whether externally rated job demand and control were associated with depression diagnosis claims in a heavy industrial cohort. The retrospective cohort sample consisted of 7,566 hourly workers aged 18–64 years who were actively employed at 11 US plants between January 1, 1996, and December 31, 2003, and free of depression diagnosis claims during an initial 2-year run-in period. Logistic regression analysis was used to model the effect of tertiles of demand and control exposure on depression diagnosis claims. Demand had a significant positive association with depression diagnosis claims in bivariate models and models adjusted for demographic (age, gender, race, education, job grade, tenure) and lifestyle (smoking status, body mass index, cholesterol level) variables (high demand odds ratio = 1.39, 95% confidence interval: 1.04, 1.86). Control was associated with greater risk of depression diagnosis at moderate levels in unadjusted models only (odds ratio = 1.47, 95% confidence interval: 1.12, 1.93), while low control, contrary to expectation, was not associated with depression. The effects of the externally rated demand exposure were lost with adjustment for location. This may reflect differences in measurement or classification of exposure, differences in depression diagnosis by location, or other location-specific factors

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy

One of the goals of antiretroviral therapy (ART) is to attenuate HIV-induced systemic immune activation and inflammation. We determined the dynamics of biomarkers of immune activation, microbial translocation and inflammation during initial ART with a nucleos(t)ide-sparing regimen of darunavir/ritonavir plus raltegravir. We also evaluated associations between these biomarkers and the virological response to the regimen

Mechanical characteristics of groundnut shell particle reinforced polylactide nano fibre

ABSTRACT The PLA-groundnut shell solution is electrospun to produce nanocomposite fibre. The spinneret containing the composite solution was placed 24.7 cm away from the aluminium collector, tilted at an angle of 30 °, and the solution flow rate kept at 1 mL/min. Groundnut Shell particle (GSP) weight fraction used was varied from 3 - 8 wt. %. Particle reinforced nanofibres were formed on the collector from the composite solution at 26 kV. These nanofibres were subjected to tensile test and the result indicates that at 6 wt. % untreated GSP reinforced fibre possessed the best tensile stiffness of 24.62 MPa. This corresponds to 2.201 % increase in Modulus of Elasticity over the unreinforced PLA (1.07 MPa). The 7 wt. % treated GSP fibre showed the least stiffness (0.33 MPa), which is 69 % reduction over that of unreinforced fibre. PLA fibre reinforced with 5 wt. % untreated GSP displayed best blend of properties over the unreinforced with increase of 286 % (4.43 x 10-4 HB), 1,502 % (1.07 MPa), 286 % (0.22 MPa), 6.8 % (0.05 J) and 1,081 % (~ 0.15 MPa) in hardness, stiffness, UTS, energy at break and stress at break respectively. However, ductility decreased by ~33.3 % when compared to the unreinforced (18.27). The 5 wt. % untreated GSP PLA reinforced fibre showed the highest UTS (0.855 MPa). The micrographs showed beads on reinforced fibres, while the virgin PLA showed no beads